Troubling headlines have been cropping up across Asia: Patients who were diagnosed with COVID-19 and seemingly recovered have been readmitted to the hospital after testing positive for the virus again ...
Epcoritamab plus R-DHAX/C achieved 79% ORR and 69% CR, with median 1.4 months to response and early activity evident by the first week-6 assessment. Over half of patients reached ASCT after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results